Literature DB >> 2570995

Retinoic acid therapy for promyelocytic leukaemia.

C Chomienne, P Ballerini, N Balitrand, M Amar, J F Bernard, P Boivin, M T Daniel, R Berger, S Castaigne, L Degos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2570995     DOI： 10.1016/s0140-6736(89)90812-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  21 in total

1.  All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells.

Authors:  C Chomienne; N Balitrand; P Ballerini; S Castaigne; H de Thé; L Degos
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

Review 2.  Delivery of retinoid-based therapies to target tissues.

Authors:  Alexander R Moise; Noa Noy; Krzysztof Palczewski; William S Blaner
Journal:  Biochemistry       Date:  2007-03-23       Impact factor: 3.162

3.  All-trans-retinoic acid: a phase II Radiation Therapy Oncology Group study (RTOG 91-13) in patients with recurrent malignant astrocytoma.

Authors:  S Phuphanich; C Scott; A J Fischbach; C Langer; W K Yung
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

4.  The treatment of recurrent cerebral gliomas with all-trans-retinoic acid (tretinoin).

Authors:  S E Kaba; A P Kyritsis; C Conrad; M J Gleason; R Newman; V A Levin; W K Yung
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

5.  Identification of FDA-Approved Oncology Drugs with Selective Potency in High-Risk Childhood Ependymoma.

Authors:  Andrew M Donson; Vladimir Amani; Elliot A Warner; Andrea M Griesinger; Davis A Witt; Jean M Mulcahy Levy; Lindsey M Hoffman; Todd C Hankinson; Michael H Handler; Rajeev Vibhakar; Kathleen Dorris; Nicholas K Foreman
Journal:  Mol Cancer Ther       Date:  2018-06-20       Impact factor: 6.261

Review 6.  New advances in the treatment of acute promyelocytic leukemia.

Authors:  Dan Douer
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

7.  Direct effects of 13-cis and all-trans retinoic acid on normal bone marrow (BM) progenitors: comparative study on BM mononuclear cells and on isolated CD34+ BM cells.

Authors:  D R van Bockstaele; M Lenjou; H W Snoeck; F Lardon; P Stryckmans; M E Peetermans
Journal:  Ann Hematol       Date:  1993-02       Impact factor: 3.673

8.  The retinoic acid analog CBS-211A potentiates the 1 alpha,25-dihydroxyvitamin D3-induced differentiation of U937 cells.

Authors:  M Taimi; H Defacque; T Commes; J Favero; J Dornand; J Marti
Journal:  Agents Actions       Date:  1993-01

Review 9.  The efficacy of 9-cis retinoic acid in experimental models of cancer.

Authors:  M M Gottardis; W W Lamph; D R Shalinsky; A Wellstein; R A Heyman
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 10.  Dietary retinol: prevention or promotion of carcinogenesis in humans?

Authors:  S T Mayne; S Graham; T Z Zheng
Journal:  Cancer Causes Control       Date:  1991-11       Impact factor: 2.506
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.